The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1041 ASCORIL SALBUTAMOL SULPHATE BP 2MG, BROMHEXINE HYDROCHLORIDE BP 8MG, GUAIFENESIN USP 100MG TABLET BLISTERPACK FOR THE SYMPTOMATIC RELIEF IN THE TREATMENT OF PRODUCTIVE COUGH ASSOCIATED WITH VARIOUS RESPIRATORY DISORDERS LIKE ACUTE BRONCHITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, PNEUMONIA, ASTHMATIC BRONCHITIS NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 06 I 2798/06 08-JAN-2024 07-JAN-2027 View
1042 BRETAM PIRACETAM 400MG CAPSULE BLISTERPACK DISEASE DUE TO CEREBRAL DAMAGE, SYMPTOMS OF CEREBRAL POST OPERATION AND CEREBRAL TRAUMA: ABALIENATION, APOPLEXY, HEMIPLEGIA, ISCHEMIA, DISEASES DUE TO PERIPHERAL DISORDER AND CEREBRAL CENTER, DISEASES DUE TO CEREBRAL DISORDER. NULL IC Pharma Lao Co., Ltd KOREA UNITED PHARM. INT'L JSC VIETNAM CERTIFICATE RELEASED 12 I 3238/08 21-MAY-2025 20-MAY-2030 View
1043 BUPISON BUPIVACAINE HYDROCHLORIDE USP EQ.TO ANHYDROUS BUPIVACAINE HYDROCHLORIDE 5 MG, DEXTROSE( MONOHYDRATE) USP 80 MG/ ML SOLUTION FOR INJECTION AMPOULES IN ADULTS AND CHILDREN OF ALL AGES FOR INTRATHECAL SPINAL ANAESTHESIA FOR SURGERY (UROLOGICAL AND LOWER LIMB SURGERY LASTING 2-3 HOURS, ABDOMINAL SURGERY LASTING 45-60 MINUTES) NULL IC Pharma Lao Co., Ltd FLAGSHIP BIOTECH INTERNATIONAL INDIA CERTIFICATE RELEASED 08 I 4776/19 07-JUN-2023 06-JUN-2026 View
1044 CADGLIM 2 GLIMEPIRIDE USP 2 MG TABLET ALU-ALU BLISTER FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS, WHEN DIET PHYSICAL EXCERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE NULL IC Pharma Lao Co., Ltd CADILA PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 03 I 5399/23 17-Mar-2023 16-Mar-2026 View
1045 CANDID - V6 CLOTRIMAZOLE USP 100 MG TABLET ALUMINIUM STRIP TREATMENT OF VULVOVAGINAL CANDIDIASIS OR CANDIDAL VULVOVAGINITIS NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2553/05 08-JAN-2024 07-JAN-2027 View
1046 CANDID DUSTING POWDER CLOTRIMAZOLE USP 1% W/W POWDER BOTTLE FOR THE TOPICAL TREATMENT OF THE SUPERFICIAL FUNGAL INFECTIONS DUE TO SUSCEPTIBLE SPECIES OCCURING IN THE SKIN FOLDS AND IN THE SWEAT ZONE AREAS. AXILLAE, INFRAMMARY FOLDS: -DERMATOPHYTE INFECTION, CUTANEOUS CANDIDIASIS, FUNGAL DIPER DERMATITIS NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 02 I 2743/06 08-JAN-2024 07-JAN-2027 View
1047 PLASMAGLUKIN DEXTAN 70.000 6G + SODIUM CHLORIDE 0.9G/500ML INFUSION Sachet PLASMA SUBSTITUTE NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR STEP 1: RECEIVE (RENEW) 08 L 0142/95 25-MAY-2022 24-MAY-2025 View
1048 CANDID EAR DROPS CLOTRIMAZOLE USP 1% W/V LIQUID BOTTLE TREATMENT OF OTOMYCOSIS, CONCOMITANT THERAPY WITH ANTIBIOTIC AND CORTICOSTEROID EAR DROPS, PROPHYLAXIS FOR SWIMMERS. NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2552/05 08-JAN-2024 07-JAN-2027 View
1049 CANDID MOUTH PAINT CLOTRIMAZOLE USP 1% W/V LIQUID BOTTLE FOR THE TOPICAL TREATMENT OF ORAL CANDIDIASIS. ORAL CANDIDIAL INFECTIONS MAY BE SEEN IN NEWBORN BABIES (ORAL THRUSH) AND IN PEDIATRIC/ADULT PATIENTS WITH ILL-FITTING DENTURES, POOR HYGIENE, ORAL INHALATIONAL STEROID… NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2549/05 08-JAN-2024 07-JAN-2027 View
1050 CANDID V-1 CLOTRIMAZOLE USP 500 MG TABLET ALUMINIUM STRIP FOR THE TREATMENT OF ACUTE AND RECURRENT VAGINAL CANDIDIASIS OR CANDIDAL VAGINITIS NULL IC Pharma Lao Co., Ltd GLENMARK PHARMACEUTICALS LIMITED INDIA CERTIFICATE RELEASED 05 I 2554/05 08-JAN-2024 07-JAN-2027 View